Edition:
India

3SBio Inc (1530.HK)

1530.HK on Hong Kong Stock

13.94HKD
18 Oct 2019
Change (% chg)

HK$-0.02 (-0.14%)
Prev Close
HK$13.96
Open
HK$14.00
Day's High
HK$14.10
Day's Low
HK$13.78
Volume
1,817,045
Avg. Vol
6,057,242
52-wk High
HK$16.42
52-wk Low
HK$8.21

Latest Key Developments (Source: Significant Developments)

3Sbio Inc Posts FY Net Profit Attributable Of RMB1,277.2 Mln
Wednesday, 20 Mar 2019 

March 20 (Reuters) - 3SBio Inc <1530.HK>::FY REVENUE INCREASED BY 22.7% TO APPROXIMATELY RMB4,583.9 MILLION.FY NET PROFIT ATTRIBUTABLE INCREASED BY 36.5% TO RMB1,277.2 MILLION.  Full Article

3SBio Inc Posts FY Net Profit Attributable RMB935.4 Mln
Monday, 26 Mar 2018 

March 26 (Reuters) - 3Sbio Inc <1530.HK>::FY NET PROFIT ATTRIBUTABLE RMB935.4 MILLION VERSUS RMB712.6 MILLION.RECOMMENDED PAYMENT OF FINAL DIVIDEND OF HKD6.85 CENTS PER ORDINARY SHARE.FY REVENUE UP 33.5% TO RMB3,734.3 MILLION.  Full Article

3Sbio Says Unit And Toray Sign Exclusive Licensing Agreement On Antipuritic Agent, TRK-820​
Monday, 15 Jan 2018 

Jan 15 (Reuters) - 3Sbio Inc <1530.HK>::UNIT AND TORAY ENTER EXCLUSIVE LICENSING AGREEMENT ON CERTAIN ORAL DISINTEGRATION TABLET FORMULATION OF ANTIPRURITIC DRUG TRK-820​.  Full Article

3SBio Says ‍China FDA Approves New Once-Weekly Bydureon To Improve Glycemic Control​
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - 3Sbio Inc <1530.HK>::‍CHINA FDA APPROVES NEW ONCE-WEEKLY BYDUREON TO IMPROVE GLYCEMIC CONTROL​.  Full Article